| Treatment |
Control |
ZnAA1 |
ZnAA2 |
P value |
| Weight gain (%) |
10.3 ± 13 |
12.8 ± 10 |
14.2 ± 8 |
0.6 |
| Estradiol (pg/ml) |
486.7 ± 151 |
634.7 ± 191.5 |
1812 ± 2215 |
0.4 |
| Histology tertiary yolk stage (TYS) |
15.5% |
50.5% |
60.3% |
- |
| Histology peri-nucleolus stage (PNS) |
51.5% |
28.7% |
20.8% |
- |
| Gonadosomatic index (%) |
5.61b ± 0.44 |
9.03a ± 2.14 |
10.22a ± 2.46 |
0.002 |
| Fecundity (egg/g) |
3034.1b ± 329 |
4955.3a ± 2028 |
5756.5a ± 1766 |
0.025 |
| Egg diameter (µm) |
1448.4b ± 79 |
1520.3a ± 132.8 |
1530.5a ± 81.0 |
0.001 |
|
| a,bValues with different superscripts in a row differ significantly (P<0.05) |
| Table 4: Maturation analysis of female C. macrocephalus with different ZnAA levels (mean ± SE). |
